Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of Hsp90-binding agents

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 3312-3318

  Bagatell, Rochelle ^a   Paine Murrieta, Gillian D ^b   Taylor, Charles W ^b   Pulcini, Elizabeth J ^a   Akinaga, Shiro ^c   Benjamin, Ivor J ^d   Whitesell, Luke ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c KYOWA HAKKO KOGYO CO LTD   (Japan)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; GELDANAMYCIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 90; PHOSPHOTRANSFERASE; RADICICOL; RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; HEAT SHOCK; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS;

3T3 CELLS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BENZOQUINONES; CELL TRANSFORMATION, VIRAL; DNA-BINDING PROTEINS; HEAT-SHOCK RESPONSE; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LACTAMS, MACROCYCLIC; LACTONES; MACROLIDES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, SCID; PAPILLOMAVIRIDAE; QUINONES; RIFABUTIN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0033890818     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Csermely, P., Schnaider, T., Soti, C., Prohaskka, Z., and Nardai, G. The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol. Ther., 79: 129-168, 1998.
2. Pratt, W. B. The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proc. Soc. Exp. Biol. Med., 217: 420-431, 1998.
3. Smith, D. F., Whitesell, L., and Katsanis, E. Molecular chaperones: biology and prospects for pharmacological intervention. Pharm. Rev., 50: 493-513, 1998.
4. Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., and Pearl, L. H. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J. Med. Chem., 42: 260-266, 1999.
5. Stebbins, C. E., Russo, A. A., Schneider, C., Rosen, N., Hartl, F. U., and Pavletich, N. P. Crystal structure of an hsp90-geldanamycin complex: targeting of a protein chaperone by an anti-tumor agent. Cell, 89: 239-250, 1997.
6. Schulte, T. W., Akinaga, S., Soga, S., Sullivan, W., Stensgard, B., Toft, D., and Neckers, L. M. Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin. Cell Stress and Chaperones, 3: 100-108, 1998.
7. Grenert, J. P., Sullivan, W. P., Fadden, P., Haystead, T. A. J., Clark, J., Mimnaugh, E., Krutzsch, H., Ochel, H-J., Schulte, T. W., Sausville, E., Neckers, L. M., and Toft, D. O. The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation. J. Biol. Chem., 272: 23843-23850, 1997.
8. Whitesell, L., and Cook, P. Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Mol. Endocrinol., 10: 705-712, 1996.
9. Segnitz, B., and Gehring, U. The function of steroid hormone receptors is inhibited by the hsp90-specific compound geldanamycin. J. Biol. Chem., 272: 18694-18701, 1997.
10. Smith, D. F., Whitesell, L., Nair, S. C., Chen, S., Prapapanich, V., and Rimerman, R. A. Progesterone receptor structure and function altered by geldanamycin, an hsp90-binding agent. Mol. Cell. Biol., 15: 6804-6812, 1995.
11. Garcia-Cardena, G., Fan, R., Shah, V., Sorrentino, R., Cirino, G., Papapetropoulos, A., and Sessa, W. C. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature (Lond.), 392: 821-824, 1998.
12. Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., and Neckers, L. M. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc. Natl. Acad. Sci., USA., 91: 8324-8328, 1994.
13. Schnur, R. C., Corman, M. L., Gallaschun, R. J., Cooper, B. A., Dee, M. F., Doty, J. L., Muzzi, M. L., Moyer, J. D., DiOrio, C. I., Barbacci, E. G., et al. Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives. J. Med. Chem., 38: 3806-3812, 1995.
14. Sharma, S. V., Agatsuma, T., and Nakano, H. Targeting of the protein chaperone, Hsp90, by the transformation suppressing agent, radicicol. Oncogene, 16: 2639-2645, 1998.
15. Schulte, T. W., Blagosklonny, M. V., Romanova, L., Mushinski, J. F., Monia, B. P., Johnston, J. F., Nguyen, P., Trepel, J., and Neckers, L. M. Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signaling pathway. Mol. Cell. Biol., 16: 5839-5845, 1996.
16. Stancato, L. F., Silverstein, A. M., Owens-Grillo, J. K., Chow, Y. H., Jove, R., and Pratt, W. B. The hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinase. J. Biol. Chem., 272: 4013-4020, 1997.
17. Whitesell, L., Sutphin, P. D., Pulcini, E. J., Martinez, J. D., and Cook, P. H. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent. Mol. Cell. Biol., 18: 1517-1524, 1998.
18. Sepehrnia, B., Paz, I. B., Dasgupta, G., and Momand, J. Heat shock protein 84 forms a complex with mutant p53 protein predominantly within a cytoplasmic compartment of the cell. J. Biol. Chem., 271: 15084-15090, 1996.
19. Blagosklonny, M. V., Toretsky, J., Bohen, S., and Neckers, L. Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90. Proc. Natl. Acad. Sci. USA, 93: 8379-8383, 1996.
20. Lawson, B., Brewer, J. W., and Hendershot, L. M. Geldanamycin, an hsp90/GRP94-binding drug, induces increased transcription of endoplasmic reticulum (ER) chaperones via the ER stress pathway. J. Cell. Physiol., 174: 170-178, 1998.
21. Hegde, R., Zuo, J., Voellmy, R., and Welch, W. Short circuiting stress protein expression via a tyrosine kinase inhibitor, herbimycin A. J. Cell. Physiol., 165: 186-200, 1995.
22. Murakami, Y., Uehara, Y., Yamamoto, C., Fukazawa, H., and Mizuno, S. Induction of Hsp 72/73 by herbimycin A, an inhibitor of transformation by tyrosine kinase oncogenes. Exp. Cell Res., 195: 338-344, 1991.
23. Nadeau, K., Das, A., and Walsh, C. T. Hsp90 chaperonins possess ATPase activity and bind heat shock transcription factors and peptidyl prolyl isomerases. J. Biol. Chem., 268: 1479-1487, 1993.
24. Naiv, S. C., Toran, E. J., Rimerman, R. A., Hjermstad, S., Smithgall, T. E., and Smith, D. F. A pathway of multi-chaperone interactions common to diverse regulatory proteins: estrogen receptor, Fes tyrosine kinase, heat shock transcription factor Hsf1 and the aryl hydrocarbon receptor. Cell Stress Chap., 1: 237-250, 1996.
25. Zou, J., Guo, Y., Toumy, G., Smith, D. F., and Voellmy, R. Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell, 94: 471-480, 1998.
26. McMillan, D. R., Xiao, X., Shao, L., Graves, K., and Benjamin, I. Targeted disruption of heat shock transcription factor 1 abolishes thermotolerance and protection against heat-inducible apoptosis. J. Biol. Chem., 273: 7523-7528, 1998.
27. Whitesell, L., Shifrin, S. D., Schwab, G., and Neckers, L. M. Benzoquinonoid ansamycins possess selective tumoricidal activity unrelated to src kinase inhibition. Cancer Res., 52: 1721-1728, 1992.
28. Paine-Murrieta, G. D., Taylor, C. W., Curtis, R. A., Lopez, M. H. A., Dorr, R. T., Johnson, C. S., Funk, C. Y., Thompson, F., and Hersh, E. M. Human tumor models in the severe combined immune deficient (scid) mouse. Cancer Chemother. Pharmacol., 40: 209-214, 1997.
29. Soga, S., Neckers, L. M., Schulte, T. W., Shiotsu, Y., Akasaka, K., Narumi, H., Agatsuma, T., Ikuina, Y., Murakata, C., Tamaoki, T., and Akinaga, S. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules. Cancer Res., 59: 2931-2938, 1999.
30. Morimoto, R. I. Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones and negative regulators. Genes Dev., 12: 3788-3796, 1998.
31. Cotto, J. J., and Morimoto, R. I. Stress-induced activation of the heat-shock response: cell and molecular biology of heat-shock factors. Biochem. Soc. Symp., 64: 105-118, 1998.
32. Cotto, J. J., Kline, M., and Morimoto, R. I. Activation of heat shock factor 1 DNA binding precedes stress-induced serine phosphorylation. Evidence for a multistep pathway of regulation. J. Biol. Chem., 271: 3355-3358, 1996.
33. Ali, A., Bharadwaj. S., O'Carroll, R., and Ovsenek, N. HSP90 interacts with and regulates the activity of heat shock factor I in Xenopus oocytes. Mol. Cell. Biol., 18: 4949-4960, 1998.
34. Shi, Y., Mosser, D. D., and Morimoto, R. I. Molecular chaperones as HSF1-specific transcriptional repressors. Genes Dev., 72: 654-666, 1998.
35. Borkovich, K. A., Farelly, F. W., Finkelstein, D. B., Taulien, J., and Lindquist, S. Hsp82 is an essential protein that is required in higher concentrations for growth of cells at high temperatures. Mol. Cell. Biol., 9: 3919-3930, 1989.
36. Benchekroun, M. N., Schneider. E., Safa, A. R., Townsend, A. J., and Sinha, B. K. Mechanisms of resistance to ansamycin antibiotics in human breast cancer cell lines. Mol. Pharmacol., 46: 677-684, 1994.
37. 14C-herbimycin A and its use in the elucidation of the kinase inactivation mechanism. FEBS Lett., 340: 155-158, 1994.
38. Uehara, Y., Fukazawa, H., Murakami, Y., and Mizuno, S. Irreversible inhibition of v-src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds. Biochem. Biophys. Res. Commun., 163: 803-809, 1989.
39. Kimura, E., Erns, R. E., Alcaraz, J. E., Arboleda, J., Slamon, D. J., and Howell, S. B. correlation of the survival of ovarian cancer patients with mRNA expression of the 60 kDa heat shock protein Hsp60. J. Clin. Oncol., 11: 891-898, 1993.
40. Ciocca, D. R., Clark, G. M., Tandon, A. K., Fuqua, S. A. W., Welch, W. J., and McGuire, W. L. Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J. Natl. Cancer Inst., 85: 570-574, 1993.
41. Marcuccilli, C. J., Mathur, S. K., Morimoto, R. I., and Miller, R. J. Regulatory differences in the stress response of hippocampal neurons and glial cells after heat shock. J. Neurosci., 16: 478-485, 1996.